Literature DB >> 22035833

Prognostic significance of neuroendocrine differentiation in prostate adenocarcinoma.

Levent Sagnak1, Hikmet Topaloglu, Ugur Ozok, Hamit Ersoy.   

Abstract

Much progress has been made toward an understanding of the development and progression of prostate cancer (PC) and the factors that drive the development of androgen independence. Neuroendocrine (NE) cells may provide an intriguing link between NE cell differentiation (NED) and tumor progression in PC. NED in PC generally confers a more aggressive clinical behavior and less favorable prognosis than conventional PC. In this article, we review the known functions of NE cells in PC and discuss the current knowledge on stimulation of cancer proliferation, invasion, apoptosis resistance, serum and immunohistochemical markers, and the prognostic significance of NED in human PC.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22035833     DOI: 10.1016/j.clgc.2011.07.003

Source DB:  PubMed          Journal:  Clin Genitourin Cancer        ISSN: 1558-7673            Impact factor:   2.872


  16 in total

1.  Androgen receptor signaling regulates T-type Ca2+ channel expression and neuroendocrine differentiation in prostate cancer cells.

Authors:  Megan Hall; Bryan Todd; Edwin D Allen; Nga Nguyen; Yoon-Jung Kwon; Vu Nguyen; Jennifer L Hearne; Miguel Martin-Caraballo
Journal:  Am J Cancer Res       Date:  2018-04-01       Impact factor: 6.166

2.  Schlafen 12 expression modulates prostate cancer cell differentiation.

Authors:  Pavlo L Kovalenko; Marc D Basson
Journal:  J Surg Res       Date:  2014-03-27       Impact factor: 2.192

3.  Endoscopic mucosal resection of duodenal bulb adenocarcinoma with neuroendocrine features: An extremely rare case report.

Authors:  Ming-Yao Wen; Yu Wang; Xiao-Yan Meng; Hua-Ping Xie
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

Review 4.  Prognostic significance of neuroendocrine differentiation in colorectal adenocarcinoma after radical operation: a meta-analysis.

Authors:  Yu-Jie Zeng; Wei Lai; Lu Liu; Heng Wu; Xing-Xi Luo; Jie Wang; Zhong-Hua Chu
Journal:  J Gastrointest Surg       Date:  2014-02-19       Impact factor: 3.452

5.  Expression and functional role of orphan receptor GPR158 in prostate cancer growth and progression.

Authors:  Nitin Patel; Tatsuo Itakura; Shinwu Jeong; Chun-Peng Liao; Pradip Roy-Burman; Ebrahim Zandi; Susan Groshen; Jacek Pinski; Gerhard A Coetzee; Mitchell E Gross; M Elizabeth Fini
Journal:  PLoS One       Date:  2015-02-18       Impact factor: 3.240

Review 6.  Prostate cancer and neuroendocrine differentiation: more neuronal, less endocrine?

Authors:  Alexandru Dan Grigore; Eshel Ben-Jacob; Mary C Farach-Carson
Journal:  Front Oncol       Date:  2015-03-03       Impact factor: 6.244

7.  FOXA1 inhibits prostate cancer neuroendocrine differentiation.

Authors:  J Kim; H Jin; J C Zhao; Y A Yang; Y Li; X Yang; X Dong; J Yu
Journal:  Oncogene       Date:  2017-03-20       Impact factor: 9.867

8.  Exposure to maternal obesogenic diet worsens some but not all pre-cancer phenotypes in a murine genetic model of prostate cancer.

Authors:  Theresa Okeyo-Owuor; Emily Benesh; Scott Bibbey; Michaela Reid; Jacques Halabi; Siobhan Sutcliffe; Kelle Moley
Journal:  PLoS One       Date:  2017-05-10       Impact factor: 3.240

Review 9.  Quality of Life and Sexual Health in the Aging of PCa Survivors.

Authors:  Mauro Gacci; Elisabetta Baldi; Lara Tamburrino; Beatrice Detti; Lorenzo Livi; Cosimo De Nunzio; Andrea Tubaro; Stavros Gravas; Marco Carini; Sergio Serni
Journal:  Int J Endocrinol       Date:  2014-03-17       Impact factor: 3.257

10.  Evaluation of protein biomarkers of prostate cancer aggressiveness.

Authors:  Anthony E Rizzardi; Nikolaus K Rosener; Joseph S Koopmeiners; Rachel Isaksson Vogel; Gregory J Metzger; Colleen L Forster; Lauren O Marston; Jessica R Tiffany; James B McCarthy; Eva A Turley; Christopher A Warlick; Jonathan C Henriksen; Stephen C Schmechel
Journal:  BMC Cancer       Date:  2014-04-05       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.